CGManalyzer: an R package for analyzing continuous glucose monitoring studies (vol 34, pg 1609, 2018)

被引：1

|

作者：

Zhang, Xiaohua Douglas

Zhang, Zhaozhi

Wang, Dandan

机构：

来源：

BIOINFORMATICS | 2018年 / 34卷 / 13期

关键词：

D O I：

10.1093/bioinformatics/bty144

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

收藏

页码：2340 / 2340

页数：1

相关论文

共 49 条

[41] Quality-of-life measures in children and adults with type 1 diabetes Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial Diabetes Care (vol 33, pg 2175, 2010)
Lawrence, Jean M.
Laffel, Lori
Wysocki, Tim
Xing, Dongyuan
Tamborlane, William V.
DIABETES CARE, 2010, 33 (12) : 2725 - 2725
[42] Assessment of the accuracy of an intermittent-scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study (vol 25, pg 586, 2021)
Toyoda, M.
Murata, T.
Saito, N.
Kimura, M.
Takahashi, H.
Ishida, N.
THERAPEUTIC APHERESIS AND DIALYSIS, 2022, 26 (02) : 484 - 484
[43] Amphetamine extended-release oral suspension (Adzenys ER (TM)) and orally disintegrating tablets (Adzenys XR-ODT (R)) in attention-deficit hyperactivity disorder: a profile of their use (vol 34, pg 411, 2018)
Lyseng-Williamson, Katherine A.
DRUGS & THERAPY PERSPECTIVES, 2018, 34 (12) : 596 - 596
[44] A randomized trial comparing the rate of hypoglycemia - assessed using continuous glucose monitoring - in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study) (vol 14, pg 593, 2013)
Thomas, D.
Reinhard, B.
Lin, P.
Areti, P.
PEDIATRIC DIABETES, 2015, 16 (06) : 462 - 462
[45] H3 relaxin inhibits the collagen synthesis via ROS- and P2X7R-mediated NLRP3 inflammasome activation in cardiac fibroblasts under high glucose (vol 22, pg 1816, 2018)
Yin, Xinhua
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (06) : 3264 - 3265
[46] InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design (vol 11, pg 1017, 2020)
Battelino, Tadej
Bosnyak, Zsolt
Danne, Thomas
Mukherjee, Bhaswati
Edelman, Steve
Pilorget, Valerie
Choudhary, Pratik
Renard, Eric
Bergenstal, Richard
DIABETES THERAPY, 2020, 11 (07) : 1607 - 1608
[47] InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design (vol 11, pg 1017, 2020)
Battelino, Tadej
Bosnyak, Zsolt
Danne, Thomas
Mukherjee, Bhaswati
Edelman, Steve
Pilorget, Valerie
Choudhary, Pratik
Renard, Eric
Bergenstal, Richard
DIABETES THERAPY, 2020, 11 (08) : 1907 - 1908
[48] Comment on: Polonsky et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study (vol 34, pg e57, 2011)
Stephens, J. W.
Carman, J. E.
Brooks, C. J.
Lyons, R. A.
Ford, D., V
Price, D. E.
Bain, S. C.
DIABETES CARE, 2011, 34 (08) : 1887 - 1887
[49] Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial (vol 10, pg 407, 2022)
Battelino, T.
Bergenstal, R. M.
Rodriguez, A.
LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (08): : E8 - E8

← 1 2 3 4 5 →